JPRN-UMIN000011638已完成2 期
Multiinstitutional study of local recurrence after pulmonary metastasectomy - Local recurrence after pulmonary metastasectomy
The Japanese Association for Metastatic Lung Tumor0 个研究点目标入组 177 人开始时间: 2013年9月8日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 177
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Non-metastatic lung tumor with wedge resection, biopsy cases
研究者
相似试验
已完成
不适用
Retrospective analysis of local recurrence and metastasis of lower lip carcinoma in patients of the maxillofacial surgery department of Oldenburg between the years 2006 and 2020.C44.0Skin of lipDRKS00011497Klinikum Oldenburg, MKG Chirurgie und plastische Operationen94
已完成
不适用
A descriptive study of Relapsing-Remitting Multiple Sclerosis (RRMS) treated with first disease modifying therapies (DMTs) in current UK clinical practice: patterns of clinical decision making and the patient experience of relapseNervous System DiseasesMultiple SclerosisMultiple sclerosisISRCTN66678006ovartis Pharmaceuticals Ltd (UK)150
已完成
不适用
Prospective multicenter study of persistent recurrence rate and the optimal observation time after endoscopic piecemeal mucosal resection for colorectal neoplaisaColorectal neoplasiaJPRN-UMIN000015740ATIONAL CANCER CENTER200
尚未招募
2 期
A retrospective cohort study based on multi-center and propensity score matching was used to evaluate the effect of Tanreqing Injection on Influence of survival prognosis in patients with severe COVID-19 infectioITMCTR2024000103The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
进行中（未招募）
1 期
A study to investigate the long-term safety and efficacy of a new drug, NI-0501, in children with a disease that is called Haemophagocytic LymphohistiocytosisHaemophagocytic lymphohistiocytosisMedDRA version: 18.0Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2012-005753-23-ATovImmune SA10